Sunday, August 3, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

Mayo Clinic Researchers Discover “Sugar Coating” Technique to Shield Cells from Type 1 Diabetes Damage

August 1, 2025
in Cancer
Reading Time: 4 mins read
0
65
SHARES
594
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

In a groundbreaking turn of biomedical research, a team at the Mayo Clinic has uncovered a novel approach to tackling type 1 diabetes by repurposing a mechanism originally observed in cancer cells. This discovery not only challenges conventional boundaries between cancer biology and autoimmune disease treatment but also paves the way for innovative therapies that could change the prognosis of this chronic disease. Type 1 diabetes, an autoimmune condition where the body’s immune system mistakenly targets and destroys insulin-producing pancreatic beta cells, currently lacks a cure, relying heavily on insulin administration and, in some cases, pancreatic islet transplantation under immunosuppression. The Mayo Clinic’s research illuminates a promising alternative grounded in molecular biotechnology and immunology.

Cancer cells have long been understood to possess an arsenal of tools that allow them to evade immune detection, one of which involves the modification of their surface with specific sugar molecules called sialic acids. These sugar moieties effectively cloak the cancer cells, enabling them to ‘fly under the radar’ of the immune system. Central to this evasion tactic is an enzyme known as ST8Sia6, which increases the density of sialic acid on the tumor cell membrane. The research team, led by immunologist Virginia Shapiro, Ph.D., hypothesized that if this same mechanism could be harnessed to protect healthy cells from aberrant immune targeting, it might serve as a powerful shield in autoimmune diseases such as type 1 diabetes.

Their recent study tested this hypothesis by genetically engineering pancreatic beta cells in preclinical mouse models prone to spontaneous autoimmune diabetes. These cells were modified to overexpress ST8Sia6, effectively ‘sugar-coating’ them with sialic acid, mirroring the immune evasion seen in tumors. Remarkably, these engineered beta cells showed a 90% efficacy rate in preventing the development of type 1 diabetes in the models. This indicates a substantial preservation of functional insulin-producing cells that would otherwise be decimated by the immune system’s misguided attack.

ADVERTISEMENT

The implications of these findings are profound. The immune tolerance induced by the engineered beta cells appears to be highly specific, meaning the immune system’s broader function remains intact. This was demonstrated by the continued activity of B and T lymphocytes and observed immune responses to other diseases within the same subjects. Such specificity suggests that therapy based on ST8Sia6 expression could provide localized immunoprotection without systemic immunosuppression, a common and risky component of current transplant protocols.

Justin Choe, M.D.-Ph.D. student and the study’s first author, highlights this selective immune modulation as a crucial step in developing curative approaches for type 1 diabetes. Rather than indiscriminately suppressing the immune system and risking opportunistic infections or cancers, the targeted enzymatic ‘sugar coating’ might teach the immune system to tolerate beta cells specifically, thus halting or preventing autoimmune destruction where it matters most.

This strategy emerges from a sophisticated understanding of the cellular glycobiology involved in immune recognition. Sialic acids on the cell surface engage with immune regulatory receptors, such as Siglecs (sialic acid-binding immunoglobulin-type lectins), which modulate immune cell activation and suppression. By amplifying sialic acid presentation through ST8Sia6 expression, engineered beta cells can actively manipulate immune checkpoints to create a tolerogenic microenvironment. This marks a significant shift from traditional immunosuppressive agents, which act broadly and disrupt immune surveillance throughout the body.

Beyond preserving endogenous beta cells, this enzymatic modification has exciting applications in islet transplantation. Current transplant recipients must endure lifelong immunosuppression to prevent graft rejection, leading to serious side effects. If pancreatic islet cells can be engineered to express ST8Sia6 and escape immune rejection, it could revolutionize transplant medicine for diabetes by eliminating the need for systemic immunosuppression, vastly improving patient outcomes and quality of life.

While the study is still in the preclinical phase, the robustness of the protective effect in spontaneous autoimmune diabetes models—considered the most clinically relevant murine models—heightens optimism for eventual translation into human therapies. The use of genetically engineered enzymes to induce immune tolerance exemplifies the emerging frontier of precision cellular therapies, where molecular insights bridge disease pathology and targeted intervention.

Dr. Shapiro emphasizes that these findings serve as an important proof-of-concept that reappropriates cancer biology insights for autoimmune disease therapy. She envisions a future where engineered beta cells or islet transplants can effectively ‘disguise’ themselves to avoid immune attack without compromising the immune system’s essential protective roles. Such a paradigm shift could ultimately culminate in more durable and less harmful treatments for millions living with type 1 diabetes worldwide.

The mechanistic insights derived from this research also deepen our understanding of immune regulation and offer a platform for exploring similar approaches in other autoimmune and inflammatory conditions. By leveraging enzymatic modulation of cell surface glycans, scientists may unlock novel ways to selectively instruct the immune system to restrain pathological self-reactivity without sacrificing overall immunocompetence.

This pioneering work received support from the National Institutes of Health and has been detailed extensively in the Journal of Clinical Investigation. It underscores Mayo Clinic’s commitment to translational research that blends fundamental science with clinical innovation to address unmet medical needs. As investigations continue, the scientific and medical communities eagerly anticipate subsequent demonstrations of safety and efficacy in human trials, which could inaugurate a new chapter in the fight against type 1 diabetes.

Subject of Research: Not explicitly provided in detail but pertains to enzymatic engineering of pancreatic beta cells to prevent autoimmune diabetes.

Article Title: ST8Sia6 overexpression protects pancreatic β cells from spontaneous autoimmune diabetes in nonobese diabetic mice

News Publication Date: 1-Aug-2025

Web References:
https://www.jci.org/articles/view/181207
https://www.mayoclinic.org/
https://www.mayoclinic.org/diseases-conditions/type-1-diabetes/symptoms-causes/syc-20353011

References:
Journal of Clinical Investigation, study by Virginia Shapiro, Ph.D. et al.

Image Credits: Not provided

Keywords: ST8Sia6, sialic acid, pancreatic beta cells, type 1 diabetes, autoimmune disease, immune tolerance, glycobiology, enzyme engineering, islet transplantation, immunosuppression, Mayo Clinic, cancer immune evasion

Tags: breakthroughs in diabetes researchcancer cell evasion strategiesimmune system and chronic diseasesinnovative therapies for autoimmune diseasesMayo Clinic research on type 1 diabetesmolecular biotechnology in diabetesnovel approaches to diabetes managementpancreatic beta cell protectionrepurposing cancer biology in diabetes treatmentsialic acids in immunologyST8Sia6 enzyme functionsugar coating technique for cells
Share26Tweet16
Previous Post

Editorial Calls for Greater Emphasis on Heart-Lung Interactions in Pulmonary Vascular Disease Research

Next Post

Oven-Temperature Treatment (~300℃) Enhances Catalyst Performance by Six Times

Related Posts

blank
Cancer

NSUN5 Drives Liver Cancer via m5C-EFNA3 Glycolysis

August 3, 2025
blank
Cancer

Predicting Hidden Cervical Cancer via Cytology, ECC

August 3, 2025
blank
Cancer

Tyrosine Kinase Inhibitors: New Frontiers in Colorectal Cancer

August 3, 2025
blank
Cancer

Zinc Finger Protein 683 Predicts Kidney Cancer Immunity

August 3, 2025
blank
Cancer

30-Hydroxygambogic Acid Boosts Cisplatin Against HPV+ Cancer

August 3, 2025
blank
Cancer

Watch-and-Wait After Immuno-Chemotherapy in NPC

August 3, 2025
Next Post
blank

Oven-Temperature Treatment (~300℃) Enhances Catalyst Performance by Six Times

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27529 shares
    Share 11008 Tweet 6880
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    936 shares
    Share 374 Tweet 234
  • Bee body mass, pathogens and local climate influence heat tolerance

    640 shares
    Share 256 Tweet 160
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    506 shares
    Share 202 Tweet 127
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    310 shares
    Share 124 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Coping Styles Linked to Substance Use in Psychiatry
  • NSUN5 Drives Liver Cancer via m5C-EFNA3 Glycolysis
  • Noradrenaline Boosts Amygdala Memory Precision for Similar Events
  • Rigid Crosslinker Enables Nondestructive Patterned QLEDs

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,184 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading